Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 4,449 | 3,425 | 12,920 | 2,895 | 8,470 |
| Cost of Goods | 3,573 | 175 | 1,227 | 144 | 677 |
| Gross Profit | 876 | 3,250 | 11,693 | 2,751 | 7,793 |
| Operating Expenses | 25,244 | 23,911 | 27,077 | 18,259 | 14,722 |
| Operating Income | -23,795 | -20,486 | -15,157 | -15,364 | -6,252 |
| Interest Expense | 2,110 | 735 | 756 | 366 | 197 |
| Other Income | 6,050 | 4,529 | -3,979 | 5,540 | 3,802 |
| Pre-tax Income | -19,855 | -16,692 | -19,892 | -10,190 | -2,647 |
| Income Tax | 70 | -70 | N/A | 177 | -74 |
| Net Income Continuous | -19,925 | -16,622 | -19,892 | -10,367 | -2,573 |
| Net Income | $-19,925 | $-16,622 | $-19,892 | $-10,367 | $-2,573 |
| EPS Basic Total Ops | -0.48 | -0.40 | -0.54 | -0.30 | -0.08 |
| EPS Basic Continuous Ops | -0.48 | -0.40 | -0.54 | -0.30 | -0.08 |
| EPS Diluted Total Ops | -0.48 | -0.40 | -0.54 | -0.30 | -0.08 |
| EPS Diluted Continuous Ops | -0.48 | -0.40 | -0.54 | -0.30 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.40 | -0.40 | N/A | N/A |
| EBITDA(a) | $-22,233 | $-18,924 | $-14,370 | $-15,302 | $-6,174 |